High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$132K
$132,931
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
|
KURA
S
Kura Oncology, Inc.
DOYLE THOMAS JAMES
• Officer • SVP, Finance & Accounting
Discretionary Sell
2026-01-27
$41,593x4
|
||||||
| KURA |
Kura Oncology, Inc.
|
Officer • SVP, Finance & Accounting
Discretionary Sell
|
2026-01-27 | $41,593x4 | S | Form 4 |
|
KURA
S
Kura Oncology, Inc.
DOYLE THOMAS JAMES
• Officer • SVP, Finance & Accounting
Discretionary Sell
2025-11-14
$50,732
|
||||||
| KURA |
Kura Oncology, Inc.
|
Officer • SVP, Finance & Accounting
Discretionary Sell
|
2025-11-14 | $50,732 | S | Form 4 |
|
KURA
S
Kura Oncology, Inc.
DOYLE THOMAS JAMES
• Officer • SVP, Finance & Accounting
Discretionary Sell
2025-09-29
$40,607
|
||||||
| KURA |
Kura Oncology, Inc.
|
Officer • SVP, Finance & Accounting
Discretionary Sell
|
2025-09-29 | $40,607 | S | Form 4 |